Skip to main content
Top
Published in:

16-01-2024 | Gestational Diabetes | Original Article

Gestational diabetes mellitus in patients undergoing assisted reproductive techniques or conceiving spontaneously: an analysis on maternal and foetal outcomes

Authors: S. Burlina, M. G. Dalfrà, A. Marchetto, A. Lapolla

Published in: Journal of Endocrinological Investigation | Issue 7/2024

Login to get access

Abstract

Purpose

With the rise of medically assisted reproductive techniques (ART) the number of pregnancies complicated by gestational diabetes mellitus (GDM) has increased. The aim of this study was to evaluate retrospectively the outcomes of pregnancies complicated by GDM who conceive trough ART (cases) compared to those who conceived spontaneously (controls).

Methods

In 670 women with GDM, 229 cases and 441 controls, followed by the Diabetology of Padua, between 2010-2022, clinical-metabolic maternal characteristics and maternal-foetal outcomes were evaluated.

Results

As for the maternal clinical-metabolic characteristics, plasma glucose levels at 60’ and 120’ under oral glucose tolerance test (OGTT) at time of diagnosis were significantly higher in cases (177.4 ± 31.1 vs 170.9 ± 34.1 mg/dl, p = 0.016; 151.5 ± 32.2 vs 144.0 ± 33.4 mg/dl, p = 0.005 respectively). Furthermore, at diagnosis, cases show higher levels of total cholesterol (257 ± 53 mg/dl vs 246 ± 52 mg/dl; p = 0.012) and triglycerides (199.8 ± 83.2 mg/dl vs 184.9 ± 71.3 mg/dl; p = 0.02) compared to controls. As for maternal outcomes, thyroid disfunction, was recorded in a higher percentage in case (21.4% vs 14.3%; p = 0.008), as well as, the frequency of cesarean section (50.3% vs 41.2%; p = 0.038) and twin pregnancies (16.2% vs 2.5%; p < 0.001). As for neonatal outcomes, there were no statistically significant differences, except for the birth weight of the second twin, which was significantly lower in cases (2268 ± 536 vs 2822 ± 297 g; p = 0.002). No other significant differences were found.

Conclusion

This study showed no meaningful differences in the outcomes of GDM pregnancies who were conceived with ART compared to that arose spontaneously as the patients were promptly diagnosed and treated.
Literature
2.
go back to reference Eskew AM, Jungheim ES (2017) A history of developments to improve in vitro fertilization. Mol Med 114(3):156–159 Eskew AM, Jungheim ES (2017) A history of developments to improve in vitro fertilization. Mol Med 114(3):156–159
5.
go back to reference Terho AM, Pelkonen S, Opdahl S, Romundstad LB, Bergh C, Wennerholm UB et al (2021) High birth weight and large-for-gestational-age in singletons born after frozen compared to fresh embryo transfer, by gestational week: a Nordic register study from the CoNARTaS group. Hum Reprod 36(4):1083–1092. https://doi.org/10.1093/humrep/deaa304CrossRefPubMed Terho AM, Pelkonen S, Opdahl S, Romundstad LB, Bergh C, Wennerholm UB et al (2021) High birth weight and large-for-gestational-age in singletons born after frozen compared to fresh embryo transfer, by gestational week: a Nordic register study from the CoNARTaS group. Hum Reprod 36(4):1083–1092. https://​doi.​org/​10.​1093/​humrep/​deaa304CrossRefPubMed
6.
go back to reference Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A (2012) Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update 18(5):485–503CrossRefPubMed Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A (2012) Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update 18(5):485–503CrossRefPubMed
8.
go back to reference Zhu L, Zhang Y, Liu Y et al (2016) Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: a retrospective cohort study. Sci Rep 6:35141CrossRefPubMedPubMedCentral Zhu L, Zhang Y, Liu Y et al (2016) Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: a retrospective cohort study. Sci Rep 6:35141CrossRefPubMedPubMedCentral
9.
go back to reference Ashrafi M, Gosili R, Hosseini R, Arabipoor A, Ahmadi J, Chehrazi M (2014) Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. Eur J Obstet Gynecol Reprod Biol 176:149–152 Ashrafi M, Gosili R, Hosseini R, Arabipoor A, Ahmadi J, Chehrazi M (2014) Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. Eur J Obstet Gynecol Reprod Biol 176:149–152
12.
go back to reference International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International Association of Diabetes and Pregnancy Study Groups: Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–768CrossRefPubMedCentral International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International Association of Diabetes and Pregnancy Study Groups: Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–768CrossRefPubMedCentral
13.
go back to reference Lapolla A, Metzger BE (2018) The post-HAPO situation with gestational diabetes: the bright and dark sides. Acta Diabetol 55(9):885–892CrossRefPubMed Lapolla A, Metzger BE (2018) The post-HAPO situation with gestational diabetes: the bright and dark sides. Acta Diabetol 55(9):885–892CrossRefPubMed
14.
go back to reference Kampmann U, Knorr S, Fuglsang J, Ovesen P (2019) Determinants of maternal insulin resistance during pregnancy: an updated over review. J Diabetes Research ID 5320156 Kampmann U, Knorr S, Fuglsang J, Ovesen P (2019) Determinants of maternal insulin resistance during pregnancy: an updated over review. J Diabetes Research ID 5320156
15.
go back to reference Lain K, Catalano PM (2007) Metabolic changes in pregnancy. Clin Obstet Gynaecol 50:938–948CrossRef Lain K, Catalano PM (2007) Metabolic changes in pregnancy. Clin Obstet Gynaecol 50:938–948CrossRef
16.
go back to reference Lapolla A, Dalfrà MG, Mello G, Parretti E, Cioni R, Marzari C et al (2008) Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab 93:876–880CrossRefPubMed Lapolla A, Dalfrà MG, Mello G, Parretti E, Cioni R, Marzari C et al (2008) Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab 93:876–880CrossRefPubMed
17.
go back to reference Dalfrà MG, Burlina S, Del Vescovo GG, Lapolla A (2020) Genetics and epigenetics, new insight on gestational diabetes mellitus. Front Endocrinol (Lausanne) 11:602477CrossRefPubMed Dalfrà MG, Burlina S, Del Vescovo GG, Lapolla A (2020) Genetics and epigenetics, new insight on gestational diabetes mellitus. Front Endocrinol (Lausanne) 11:602477CrossRefPubMed
18.
go back to reference Hod M, Kapur A, Sacks DA et al (2015) The international federation of gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173-211CrossRefPubMed Hod M, Kapur A, Sacks DA et al (2015) The international federation of gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173-211CrossRefPubMed
19.
go back to reference ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al on behalf of the American Diabetes Association (2023) Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S254–S266. https://doi.org/10.2337/dc23-S015 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al on behalf of the American Diabetes Association (2023) Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S254–S266. https://​doi.​org/​10.​2337/​dc23-S015
20.
go back to reference Burlina S, Dalfrà MG, Lapolla A (2019) Short- and long-term consequences for offspring exposed to maternal diabetes: a review. J Matern Fetal Neonatal Med 32(4):687–694CrossRefPubMed Burlina S, Dalfrà MG, Lapolla A (2019) Short- and long-term consequences for offspring exposed to maternal diabetes: a review. J Matern Fetal Neonatal Med 32(4):687–694CrossRefPubMed
21.
go back to reference Burlina S, Dalfrà MG, Lapolla A (2018) Clinical and biochemical approach to predicting post-pregnancy metabolic decompensation. Diabetes Res Clin Pract 145:178–183CrossRefPubMed Burlina S, Dalfrà MG, Lapolla A (2018) Clinical and biochemical approach to predicting post-pregnancy metabolic decompensation. Diabetes Res Clin Pract 145:178–183CrossRefPubMed
23.
go back to reference Choe J, Shanks AL. In Vitro Fertilization (2022) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Choe J, Shanks AL. In Vitro Fertilization (2022) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
25.
go back to reference Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines (2009). Weight gain during pregnancy: reexamining the guidelines. Washington (DC) Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines (2009). Weight gain during pregnancy: reexamining the guidelines. Washington (DC)
26.
go back to reference AMD-SID (2018) Standard Italiani per la Cura del Diabete Mellito. AMD-SID (2018) Standard Italiani per la Cura del Diabete Mellito.
27.
go back to reference Huggett AS, Nixon DA (1957) Use of glucoseoxidase, peroxidase, and O-dianisidine in determination of blood and urinaryglucose. Lancet 273(6991):368–370CrossRefPubMed Huggett AS, Nixon DA (1957) Use of glucoseoxidase, peroxidase, and O-dianisidine in determination of blood and urinaryglucose. Lancet 273(6991):368–370CrossRefPubMed
28.
go back to reference Mosca A, Paleari R, Dalfrà MG, DiCianni G, Cuccuru I, Pellegrini G et al (2006) Reference intervals for hemoglobin A1c in pregnant women:data from an Italian multicenter study. Clin Chem 52:1138–1143CrossRefPubMed Mosca A, Paleari R, Dalfrà MG, DiCianni G, Cuccuru I, Pellegrini G et al (2006) Reference intervals for hemoglobin A1c in pregnant women:data from an Italian multicenter study. Clin Chem 52:1138–1143CrossRefPubMed
29.
go back to reference Dastych M, Wiewiofka O, Benovska M (2014) Ethamsylate (Dicynone) interference in determination of serum creatinine, uric acid, triglycerides and cholesterol in assays involving the Trinder reaction: in vivo and in vitro. Clin Lab 204(60):1373–1376 Dastych M, Wiewiofka O, Benovska M (2014) Ethamsylate (Dicynone) interference in determination of serum creatinine, uric acid, triglycerides and cholesterol in assays involving the Trinder reaction: in vivo and in vitro. Clin Lab 204(60):1373–1376
30.
go back to reference Sakay H, Fukuda G, Suzuki N et al (2009) Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J 56(3):435–440CrossRef Sakay H, Fukuda G, Suzuki N et al (2009) Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J 56(3):435–440CrossRef
31.
go back to reference Parazzini F, Cortinovis I, Bortolus R, Fedele L, Recarli A (1995) (1995) Weight at birth by gestational age in Italy. HumReproduct 10:1862–1863 Parazzini F, Cortinovis I, Bortolus R, Fedele L, Recarli A (1995) (1995) Weight at birth by gestational age in Italy. HumReproduct 10:1862–1863
33.
go back to reference Szymanska M, Horosz E, Szymusik I, Bomba-Opon D, Wielgos M (2011) Gestational diabetes in IVF and spontaneous pregnancies. Neuro Endocrinol Lett 32(6):885–888PubMed Szymanska M, Horosz E, Szymusik I, Bomba-Opon D, Wielgos M (2011) Gestational diabetes in IVF and spontaneous pregnancies. Neuro Endocrinol Lett 32(6):885–888PubMed
38.
go back to reference Mintziori G, Anagnostis P, Toulis KA, Goulis DG (2012) Thyroid diseases and female reproduction. Minerva Med 103(1):47–62PubMed Mintziori G, Anagnostis P, Toulis KA, Goulis DG (2012) Thyroid diseases and female reproduction. Minerva Med 103(1):47–62PubMed
47.
go back to reference Periera MM, Mainigi M, Strauss JF (2021) Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update 27:651–672CrossRef Periera MM, Mainigi M, Strauss JF (2021) Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update 27:651–672CrossRef
49.
go back to reference WHO Policy Brief Preconception care (2013) Maximizing the gains for maternal and child health. 1–8 WHO Policy Brief Preconception care (2013) Maximizing the gains for maternal and child health. 1–8
Metadata
Title
Gestational diabetes mellitus in patients undergoing assisted reproductive techniques or conceiving spontaneously: an analysis on maternal and foetal outcomes
Authors
S. Burlina
M. G. Dalfrà
A. Marchetto
A. Lapolla
Publication date
16-01-2024
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 7/2024
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02282-2

Other articles of this Issue 7/2024

Journal of Endocrinological Investigation 7/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare